Loading... Please wait...

Eloxx Pharmaceuticals, Inc. (ELOX) Ownership

Currency in USD Disclaimer
$0.75 $0.03 (4.17%)
$0.75
$0.75
$0.4
$10.5
  • RECENT QUARTER TOTAL INVESTED

    $27,000

      -$2.11 M

  • RECENT QUARTER INSTITUTIONAL OWNERSHIP PERCENTAGE

    0.68%

      -584.05%

  • TOTAL INVESTED OF LAST QUARTER

    $2.14 M
  • OWNERSHIP PERCENTAGE OF LAST QUARTER

    584.73%
*Showing results of the last quarter update.

Eloxx Pharmaceuticals, Inc. Major Shareholders & Ownership History


Reporting Date Major Shareholder Name Shares Held Market Value Change in Shares Ownership
02/13/2023 CLAL INSURANCE ENTERPRISES HOLDINGS LTD 14,626 $27,000   -97.50% 0.68%
02/13/2023 JPMORGAN CHASE & CO 0 $0   -100.00% 0.00%
02/10/2023 BANK OF AMERICA CORP /DE/ 0 $0   -100.00% 0.00%
02/13/2023 WELLS FARGO & COMPANY/MN 0 $0   -100.00% 0.00%
02/13/2023 NORTHERN TRUST CORP 0 $0   -100.00% 0.00%
05/15/2023 STATE STREET CORP 0 $0   -100.00% 0.00%
02/10/2023 VANGUARD GROUP INC 0 $0   -100.00% 0.00%
02/14/2023 MEEDER ASSET MANAGEMENT INC 0 $0   -100.00% 0.00%
02/14/2023 CREDIT SUISSE AG/ 0 $0   -100.00% 0.00%
02/14/2023 MORGAN STANLEY 0 $0   -100.00% 0.00%
01/24/2023 NATIONAL BANK OF CANADA /FI/ 0 $0   -100.00% 0.00%
02/09/2023 GROUP ONE TRADING, L.P. 0 $0   -100.00% 0.00%
02/13/2023 RENAISSANCE TECHNOLOGIES LLC 0 $0   -100.00% 0.00%
02/13/2023 AMERICAN FINANCIAL GROUP INC 0 $0   -100.00% 0.00%
02/14/2023 BRIDGEWAY CAPITAL MANAGEMENT, LLC 0 $0   -100.00% 0.00%
02/14/2023 BNP PARIBAS ARBITRAGE, SNC 0 $0   -100.00% 0.00%
02/13/2023 GEODE CAPITAL MANAGEMENT, LLC 0 $0   -100.00% 0.00%
05/09/2023 ALTSHULER SHAHAM LTD 0 $0   -100.00% 0.00%
02/14/2023 MENORA MIVTACHIM HOLDINGS LTD. 0 $0   -100.00% 0.00%
02/13/2023 BLACKROCK INC. 0 $0   -100.00% 0.00%
02/14/2023 BANK OF NEW YORK MELLON CORP 0 $0   -100.00% 0.00%
02/14/2023 CITADEL ADVISORS LLC 0 $0   -100.00% 0.00%
01/26/2023 HAREL INSURANCE INVESTMENTS & FINANCIAL SERVICES LTD. 0 $0   -100.00% 0.00%
03/15/2023 B. RILEY WEALTH ADVISORS, INC. 0 $0   -100.00% 0.00%
02/02/2023 SIMPLEX TRADING, LLC 0 $0   -100.00% 0.00%
02/10/2023 TOWER RESEARCH CAPITAL LLC (TRC) 0 $0   -100.00% 0.00%
02/15/2023 VIRTU FINANCIAL LLC 0 $0   -100.00% 0.00%
02/15/2023 JANE STREET GROUP, LLC 0 $0   -100.00% 0.00%
02/10/2023 ADVISOR GROUP HOLDINGS, INC. 0 $0   -100.00% 0.00%
01/18/2023 VANGUARD CAPITAL WEALTH ADVISORS 0 $0   -100.00% 0.00%
02/14/2023 ATOM INVESTORS LP 0 $0   -100.00% 0.00%
02/14/2023 SILVERARC CAPITAL MANAGEMENT, LLC 0 $0   -100.00% 0.00%

Eloxx Pharmaceuticals, Inc. institutional Ownership - Frequently Asked Questions

  • Q. Who are the largest shareholders of ELOX shares?

    A. During the previous two years, 5 institutional investors and hedge funds held shares of Eloxx Pharmaceuticals, Inc.. The most heavily invested institutionals were:

    B. Riley Wealth Management, Inc.: 37,500

    Advisor Group, Inc.: 12,359

    LADENBURG THALMANN FINANCIAL SERVICES INC.: 1

    TIAA CREF INVESTMENT MANAGEMENT LLC: 42,529

    TEACHERS ADVISORS, LLC: 40,748

  • Q. What percentage of Eloxx Pharmaceuticals, Inc. stock is owned by institutional investors?

    A. 0.68% of Eloxx Pharmaceuticals, Inc. stock is owned by institutional investors.

  • Q. How much institutional buying is happening at ELOX ?

    A. Institutional investors have bought a total of 133,137 shares in the last 24 months. This purchase volume represents approximately $99,853 in transactions.

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.